Integrated network pharmacology, molecular simulation and in vitro validation identify salidroside as a representative active constituent of Rhodiola rosea against non-small cell lung cancer

Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality, and its progression involves multiple biological processes. Rhodiola rosea has attracted increasing attention owing to its diverse pharmacological activities; however, the potential anti-NSCLC mechanisms and key active compounds of Rhodiola rosea remain insufficiently elucidated. This study aimed to develop an integrated computational and experimental framework to explore potential anti-NSCLC targets and cellular effects of Rhodiola rosea. Integrated analysis of network pharmacology and NSCLC transcriptomic data identified seven active compounds of Rhodiola rosea: 7-hydroxycoumarin, caffeic acid, kaempferol, 3,4,5-trihydroxybenzoic acid, salidroside, ethyl gallate, and tyrosol. The same analysis identified seven candidate hub proteins: AURKA, CCNA2, CHEK1, KIF11, MMP9, TK1, and TYMS. Molecular docking and molecular dynamics simulations suggested that these compounds could occupy the corresponding binding pockets and maintain stable poses during simulation. In A549 cells, salidroside reduced cell viability, induced apoptosis, increased reactive oxygen species (ROS), and decreased mitochondrial membrane potential. Western blotting showed that salidroside reduced the abundance of KIF11/Eg5, MMP9, AURKA, CCNA2, CHEK1, TK1, and TYMS in A549 cells, with concordant reductions in H1975 cells. Similar dose-dependent changes in viability, apoptosis, ROS, and mitochondrial membrane potential were also observed in H1975 cells, and BEAS-2B viability was assessed in parallel. These in vitro findings support a potential association between salidroside exposure and these cellular changes, but do not establish direct target engagement or a causal ROS-dependent mechanism.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-19
DOI
https://doi.org/10.3389/fphar.2026.2018395
Primary Topic
Medicinal Plants and Bioactive Compounds
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrated network pharmacology, molecular simulation and in vitro validation identify salidroside as a representative active constituent of Rhodiola rosea against non-small cell lung cancer

Shilan Liu, Bo Liu, Yingxue Hu, Jiale Hu et al.
Frontiers in Pharmacology
Medicinal Plants and Bioactive Compounds
article

Integrated network pharmacology, molecular simulation and in vitro validation identify salidroside as a representative active constituent of Rhodiola rosea against non-small cell lung cancer

Shilan Liu, Bo Liu, Yingxue Hu, Jiale Hu, NI Pingwei, Shanmei Liu, Xiao Liu, Qinghui Yang
article en

Abstract

Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality, and its progression involves multiple biological processes. Rhodiola rosea has attracted increasing attention owing to its diverse pharmacological activities; however, the potential anti-NSCLC mechanisms and key active compounds of Rhodiola rosea remain insufficiently elucidated. This study aimed to develop an integrated computational and experimental framework to explore potential anti-NSCLC targets and cellular effects of Rhodiola rosea. Integrated analysis of network pharmacology and NSCLC transcriptomic data identified seven active compounds of Rhodiola rosea: 7-hydroxycoumarin, caffeic acid, kaempferol, 3,4,5-trihydroxybenzoic acid, salidroside, ethyl gallate, and tyrosol. The same analysis identified seven candidate hub proteins: AURKA, CCNA2, CHEK1, KIF11, MMP9, TK1, and TYMS. Molecular docking and molecular dynamics simulations suggested that these compounds could occupy the corresponding binding pockets and maintain stable poses during simulation. In A549 cells, salidroside reduced cell viability, induced apoptosis, increased reactive oxygen species (ROS), and decreased mitochondrial membrane potential. Western blotting showed that salidroside reduced the abundance of KIF11/Eg5, MMP9, AURKA, CCNA2, CHEK1, TK1, and TYMS in A549 cells, with concordant reductions in H1975 cells. Similar dose-dependent changes in viability, apoptosis, ROS, and mitochondrial membrane potential were also observed in H1975 cells, and BEAS-2B viability was assessed in parallel. These in vitro findings support a potential association between salidroside exposure and these cellular changes, but do not establish direct target engagement or a causal ROS-dependent mechanism.

Frontiers in PharmacologyVol. 17
Chengdu Fifth People's Hospital (CN), Chengdu University of Traditional Chinese Medicine (CN)
Medicinal Plants and Bioactive Compounds
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon